Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20230627058603N2
IRCT20230627058603N2RecruitingPhase 2

Investigating the effectiveness of Rosuvastatin in patients with moderate brain trauma

Esfahan University of Medical Sciences0 sites200 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
200
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
no limit to no limit (—)
Sex
All

Inclusion Criteria

  • •Patients with a level of consciousness between 8-12
  • •Informed consent of first-degree companions to enter the study

Exclusion Criteria

  • •History of any brain disorders
  • •Normal Liver function tests

Investigators

Similar Trials

Completed
Not Applicable
A study to evaluate the efficacy of Rosuvastatin for patients with coronary plaque utilizing aggressive lipid lowering treatmentHypercholesterolemia
JPRN-UMIN000001223Kokura Memorial Hospital400
Recruiting
Phase 3
A clinical trial to investigate the efficiency of rosuvastatin in acute cardiomyopathy induced anthracyclineCardiomyopathy
IRCT2016121213090N3Vice chancellor for research of Mazandaran University of Medical Sciences80
Completed
Phase 3
The assessment of effect of Rosuvastatin use in venous thromboembolismVenous thromboembolism includes deep vein thrombosis and pulmonary embolism.venous embolism and thrombosisCode I82
IRCT20210416050990N1Shahid Beheshti University of Medical Sciences220
Completed
Phase 3
Evaluation of the effects of Rosuvastatin in the treatment of patients with deep vein thrombosis(DVT)
IRCT20150621022852N4Shahid Beheshti University of Medical Sciences50
Recruiting
Phase 3
Sinus lift surgery with Dental Implants using Rosuvastatin and I-PRF
CTRI/2022/08/044627Dr Lahari Buggapati